Pulmonary drug delivery strategies: A concise, systematic review

被引:169
作者
Patil, J. S. [1 ]
Sarasija, S. [2 ]
机构
[1] BLDE Univ Campus, BLDEAs Coll Pharm, Dept Pharmaceut, Bijapur, India
[2] Al Ameen Coll Pharm, Dept Pharmaceut, Bangalore, Karnataka, India
关键词
Dry powder inhaler; lung deposition; pulmonary route; targeted drug delivery;
D O I
10.4103/0970-2113.92361
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Because of limitations associated with the conventional treatment of various chronic diseases a growing attention has been given to the development of targeted drug delivery systems. Pulmonary route of drug delivery gaining much importance in the present day research field as it enables to target the drug delivery directly to lung both for local and systemic treatment. Over the last 2 decades, the systemic absorption of a broad range of therapeutics after pulmonary application has been demonstrated in animals as well as in humans. This review was prepared with an aim to discuss the technical, physiological, and efficacy aspects of the novel pulmonary route of drug targeting. The review also focuses on the mechanisms of pulmonary drug administration along with compatibility of the excipients employed, devices used, and techniques of particulate dosage production. This review was prepared based on the method of extensive literature survey on the topics covering all the aspects discussed in the present subject. Hence, the better understanding of complexes and challenges facing the development of pulmonary drug delivery system offer an opportunity to the pharmaceutical scientist in minimizing the clinical and technical gaps.
引用
收藏
页码:44 / 49
页数:6
相关论文
共 49 条
  • [1] BUDESONIDE - AN UPDATED REVIEW OF ITS PHARMACOLOGICAL PROPERTIES, AND THERAPEUTIC EFFICACY IN ASTHMA AND RHINITIS
    BROGDEN, RN
    MCTAVISH, D
    [J]. DRUGS, 1992, 44 (03) : 375 - 407
  • [2] Chan HK, 2003, EXPERT OPIN THER PAT, V13, P1333, DOI 10.1517/eotp.13.9.1333.22942
  • [3] Production of solid lipid nanoparticle suspensions using supercritical fluid extraction of emulsions (SFEE) for pulmonary delivery using the AERx system
    Chattopadhyay, P.
    Shekunov, B. Y.
    Yim, D.
    Cipolla, D.
    Boyd, B.
    Farr, S.
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (06) : 444 - 453
  • [4] Influence of particle size on drug delivery to rat alveolar macrophages following pulmonary administration of ciprofloxacin incorporated into liposomes
    Chono, Sumio
    Tanino, Tomoharu
    Seki, Toshinobu
    Morimoto, Kazuhiro
    [J]. JOURNAL OF DRUG TARGETING, 2006, 14 (08) : 557 - 566
  • [5] Effect of design on the performance of a dry powder inhaler using computational fluid dynamics. Part 1: Grid structure and mouthpiece length
    Coates, MS
    Fletcher, DF
    Chan, HK
    Raper, JA
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 93 (11) : 2863 - 2876
  • [6] Systemic delivery of parathyroid hormone (1-34) using inhalation dry powders in rats
    Codrons, V
    Vanderbist, F
    Verbeeck, RK
    Arras, M
    Lison, D
    Préat, V
    Vanbever, R
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 92 (05) : 938 - 950
  • [7] A novel method for assessing dissolution of aerosol inhaler products
    Davies, NM
    Feddah, MIR
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 255 (1-2) : 175 - 187
  • [8] Degim IT, 2007, CURR PHARM DESIGN, V13, P99
  • [9] Improved lung delivery from a passive dry powder inhaler using an engineered PulmoSphere® powder
    Duddu, SP
    Sisk, SA
    Walter, YH
    Tarara, TE
    Trimble, KR
    Clark, AR
    Eldon, MA
    Elton, RC
    Pickford, M
    Hirst, PH
    Newman, SP
    Weers, JG
    [J]. PHARMACEUTICAL RESEARCH, 2002, 19 (05) : 689 - 695
  • [10] Airway mucus: The good, the bad, the sticky
    Evans, Christopher M.
    Koo, Ja Seok
    [J]. PHARMACOLOGY & THERAPEUTICS, 2009, 121 (03) : 332 - 348